Eight more cases of rare clotting, says TGA
TGA reports eight further cases of blood clotting linked to AstraZeneca, as it urges Australians to reject the inoculation jitters and embrace the jab.
The Therapeutic Goods Administration has reported eight further cases of rare blood clotting linked to the AstraZeneca vaccine as it urges Australians to reject jab jitters and embrace inoculation.
The TGA’s weekly report says the new cases bring the total number of confirmed and probable cases of Thrombosis Thrombocytopenia Syndrome in Australia to 41, with one person critically ill.
The report shows there are four new confirmed cases of rare blood clots with TTS, and four new “probable cases”.
The four confirmed cases have been detected in a 40-year-old woman from Victoria being treated in NSW, a 70-year-old woman from Victoria, an 82-year-old woman from NSW and a 70-year-old man from Queensland.
The four probable cases have been identified as a 72- year -old man from South Australia, a 61-year-old female from NSW and a 73-year-old man and 67-year-old woman from Queensland.
The TGA has received more than 24,000 reports of adverse reactions to the vaccine, with most side effects confined to headaches, fever and muscle aches.
Despite the new cases, the TGA has stressed the rarity of clotting cases, urging Australians to consider the low degree of risk associated with the vaccine.